Posted 01 Apr 2015

Prof. Monica Di Luca

Neuroscience funding and policy



The President of the Federation of European Neuroscience Societies (FENS), Monica Di Luca, highlights the burden of neurological diseases on society and how this may grow in the future if action is not taken. She states that if the effects of degenerative diseases like Alzheimer's disease could be delayed by five years, the overall cost worldwide could be halved.

About speaker:
Prof. Monica Di Luca has been professor of Pharmacology at the University of Milano since 1999.

She graduated in Pharmacology at the University of Milano, in 1992 she discussed her PhD thesis at the University of Milano, and in 1993 she completed a PhD programme in Molecular Biology at the University of Utrecht. Her primary research interest in related to brain and synaptic plasticity both in physiological and pathological conditions, with the primary aim to apply her basic findings to the cure of neurodegenerative diseases as Alzheimer Disease. She is author of more that 190 scientific publications on peer reviewed journals.

She is member of Council and Executive committee of several national and international scientific organization. From 2000 to 2006 she performed as secretary general of Federation of European Neuroscience Societies and form 2005 to 2010 she was Chair of IBRO Western Europe Chapter. She was Vice-President of European Brain Council until 2012. At present she is President of FENS.